Xcellbio is a venture-backed cell therapy platform company based in San Francisco. We have built a proprietary suite of innovative technologies designed to enhance the performance and safety of cell and gene therapies from early discovery through clinical manufacturing. Our specialized hardware and proprietary machine learning algorithms enable researchers to improve cell therapy potency and persistence. We enable clinicians to translate these insights at patient-scale, through a novel cell therapy manufacturing technology.